Results of a qualitative and field study using the WHOQOL instrument for cancer patients

被引:31
作者
Tazaki, M [1 ]
Nakane, Y [1 ]
Endo, T [1 ]
Kakikawa, F [1 ]
Kano, K [1 ]
Kawano, H [1 ]
Kuriyama, K [1 ]
Kuroko, K [1 ]
Miyaoka, E [1 ]
Ohta, H [1 ]
Okamoto, N [1 ]
Shiratori, S [1 ]
Takamiya, S [1 ]
Tanemura, K [1 ]
Tsuchiya, R [1 ]
机构
[1] Tokyo Univ Sci, Shinjuku Ku, Tokyo 162, Japan
关键词
quality of life; WHO; cancer patients; cancer;
D O I
10.1093/jjco/28.2.134
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The main purpose of the study was to evaluate quality of life (QOL) among cancer patients using the WHOQOL-100 instrument and to see ii any significant differences were seen in cancer stages, treatment status and prognosis. This study consisted of two parts; qualitative and quantitative. For the qualitative study, two focus groups were conducted by medical professionals to establish the applicability of the WHOQOL instrument in evaluating the QOL of cancer patients, but most participants were negative about using a generic instrument such as WHOQOL. For the quantitative study, 197 cancer patients (average age 55.86) from eight medical centers using the WHOQOL instrument, in addition to each patient's information sheet filled in by their own physicians, were analyzed. The average overall QOL score was 3.39. There was high reliability (Cronbach's alpha=0.9685) and a high correlation between the psychological and the environmental domains (r=0.7021), the physical domain and the level of independence (r=0.6031) and social relations and the environment (r=0.6856) and between health conditions perceived by patients and QOL scores. In addition, differences by gender, treatments and cancer sites were also found to be significantly different at the 5% significance level. The results indicated that the WHOQOL core instrument was sensitive enough to evaluate the QOL of cancer patients.
引用
收藏
页码:134 / 141
页数:8
相关论文
共 20 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]  
BARNOFSKY I, 1990, QUALITY LIFE ASSESSM, P419
[3]  
HIRAGA I, 1992, RES TERMINAL CARE CA, P613
[4]  
*KOS, 1997, KOS
[5]  
KURIHARA M, 1993, GANN TO KAGAKURYOHO, V20, P16
[6]  
KURIHARA M, 1995, GANN TO KAGAKURYOHO, V22, P7
[7]   THE WORLD-HEALTH-ORGANIZATION QUALITY-OF-LIFE ASSESSMENT (WHOQOL) - POSITION PAPER FROM THE WORLD-HEALTH-ORGANIZATION [J].
KUYKEN, W ;
ORLEY, J ;
POWER, M ;
HERRMAN, H ;
SCHOFIELD, H ;
MURPHY, B ;
METELKO, Z ;
SZABO, S ;
PIBERNIKOKANOVIC, M ;
QUEMADA, N ;
CARIA, A ;
RAJKUMAR, S ;
KUMAR, S ;
SAXENA, S ;
BARON, D ;
AMIR, M ;
TAZAKI, M ;
NOJI, A ;
VANHECK, G ;
DEVRIES, J ;
SUCRE, JA ;
PICARDAMI, L ;
KABANOV, M ;
LOMACHENKOV, A ;
BURKOVSKY, G ;
CARRASCO, RL ;
BODHARAMIK, Y ;
MEESAPYA, K ;
SKEVINGTON, S ;
PATRICK, D ;
MARTIN, M ;
WILD, D ;
ACUDA, W ;
MUTAMBIRWA, J ;
AARONSON, NK ;
BECH, P ;
BULLINGER, M ;
CHEN, HN ;
FOXRUSHBY, J ;
MOINPOUR, C ;
ROSSER, R ;
BUESCHING, D ;
BUCQUET, D ;
CHAMBERS, LW ;
JAMBON, B ;
JENKINS, CD ;
DELEO, D ;
FALLOWFIELD, L ;
GERIN, P ;
GRAHAM, P .
SOCIAL SCIENCE & MEDICINE, 1995, 41 (10) :1403-1409
[8]   DEVELOPMENT OF THE WHOQOL - RATIONALE AND CURRENT STATUS [J].
KUYKEN, W ;
ORLEY, J .
INTERNATIONAL JOURNAL OF MENTAL HEALTH, 1994, 23 (03) :24-56
[9]  
NAKANE Y, 1996, JPN J CANC CARE, V1, P1
[10]  
NAKANE Y, 1997, NIPPON LJI SHINPO, P27